Literature DB >> 10455293

Pharmacological characterization of 5-HT4 receptors mediating relaxation of canine isolated rectum circular smooth muscle.

N H Prins1, J F Van Haselen, R A Lefebvre, M R Briejer, L M Akkermans, J A Schuurkes.   

Abstract

This study aimed to characterize for the first time in vitro 5-HT4 receptors in the canine gastrointestinal tract. For this purpose, we used circular muscle strips of the canine isolated rectum. In the presence of methysergide (60 microM), 5-HT induced relaxation of methacholine (1 microM)-precontracted muscle strips, yielding a monophasic sigmoidal concentration-relaxation curve (pEC50 7.2+/-0.07). Tetrodotoxin (0.3 microM) did not affect the curve to 5-HT, suggesting the inhibitory 5-HT receptor is located on the smooth muscle. Granisetron (0.3 microM) did also not affect the curve to 5-HT, which excludes the 5-HT3 receptor mediating the relaxation to 5-HT. The presence of methysergide rules out the involvement of 5-HT1, 5-HT2 or 5-HT7 receptors. 5-HT, the selective 5-HT4 receptor agonists R076186, prucalopride (R093877) and SDZ HTF-919 and the 5-HT4 receptor agonists cisapride and 5-MeOT relaxed the muscle strips with a rank order of potency R076186 = 5-HT > cisapride > prucalopride > or = SDZ HTF-919 > 5-MeOT. The selective 5-HT4 receptor antagonists GR 125487, RS 39604 and GR 113808 competitively antagonized the relaxations to 5-HT, yielding pK(B) estimates of 9.7, 7.9 and 9.1, respectively. The selective 5-HT4 receptor antagonist SB 204070 shifted the curve to 5-HT rightward and depressed the maximal response (apparent pA2 10.6). GR 113808 (10 nM) produced a parallel rightward shift of the curve to the selective 5-HT4 receptor agonists R076186 (pA2 8.8). It is concluded that 5-HT induces relaxation of the canine rectum circular muscle through stimulation of a single population of smooth muscle 5-HT4 receptors. For the first time, a nonhuman species was shown to exhibit relaxant 5-HT4 receptors in the large intestine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10455293      PMCID: PMC1760667          DOI: 10.1038/sj.bjp.0702665

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  The serotonin 5-HT4 receptor. 1. Design of a new class of agonists and receptor map of the agonist recognition site.

Authors:  K H Buchheit; R Gamse; R Giger; D Hoyer; F Klein; E Klöppner; H J Pfannkuche; H Mattes
Journal:  J Med Chem       Date:  1995-06-23       Impact factor: 7.446

2.  The effects of SB 204070, a highly potent and selective 5-HT4 receptor antagonist, on guinea-pig distal colon.

Authors:  K A Wardle; E S Ellis; G S Baxter; G A Kennett; L M Gaster; G J Sanger
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

3.  Further analysis of anomalous pKB values for histamine H2-receptor antagonists on the mouse isolated stomach assay.

Authors:  J W Black; P Leff; N P Shankley
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

4.  Cisapride and a structural analogue, R 76,186, are 5-hydroxytryptamine4 (5-HT4) receptor agonists on the guinea-pig colon ascendens.

Authors:  M R Briejer; L M Akkermans; A L Meulemans; R A Lefebvre; J A Schuurkes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

5.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

6.  5-Hydroxytryptamine4 receptors mediate relaxation of the rat oesophageal tunica muscularis mucosae.

Authors:  G S Baxter; D A Craig; D E Clarke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-05       Impact factor: 3.000

7.  Cisapride and 5-hydroxytryptamine enhance motility in the canine antrum via separate pathways, not involving 5-hydroxytryptamine1,2,3,4 receptors.

Authors:  W J de Ridder; J A Schuurkes
Journal:  J Pharmacol Exp Ther       Date:  1993-01       Impact factor: 4.030

8.  GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor.

Authors:  J D Gale; C J Grossman; J W Whitehead; A W Oxford; K T Bunce; P P Humphrey
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

9.  Antagonism by SB 204070 of 5-HT-evoked contractions in the dog stomach: an in-vivo model of 5-HT4 receptor function.

Authors:  S Bingham; B F King; B Rushant; M I Smith; L Gaster; G J Sanger
Journal:  J Pharm Pharmacol       Date:  1995-03       Impact factor: 3.765

10.  The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants.

Authors:  C Gerald; N Adham; H T Kao; M A Olsen; T M Laz; L E Schechter; J A Bard; P J Vaysse; P R Hartig; T A Branchek
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

View more
  21 in total

1.  An improved in vitro bioassay for the study of 5-HT(4) receptors in the human isolated large intestinal circular muscle.

Authors:  N H Prins; N P Shankley; N J Welsh; M R Briejer; R A Lefebvre; L M Akkermans; J A Schuurkes
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

2.  The in vitro pharmacological profile of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity.

Authors:  J A M Smith; D T Beattie; D Marquess; J P Shaw; R G Vickery; P P A Humphrey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-16       Impact factor: 3.000

3.  5-HT(4) receptors mediating enhancement of contractility in canine stomach; an in vitro and in vivo study.

Authors:  N H Prins; A van Der Grijn; R A Lefebvre; L M Akkermans; J A Schuurkes
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

Review 4.  Drug treatment options for irritable bowel syndrome: managing for success.

Authors:  R C Dunphy; G N Verne
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 5.  An update on prucalopride in the treatment of chronic constipation.

Authors:  Anam Omer; Eamonn M M Quigley
Journal:  Therap Adv Gastroenterol       Date:  2017-10-16       Impact factor: 4.409

6.  Prophylactic efficacy of 5-HT4R agonists against stress.

Authors:  Briana K Chen; Indira Mendez-David; Victor M Luna; Charlène Faye; Alain M Gardier; Denis J David; Christine A Denny
Journal:  Neuropsychopharmacology       Date:  2019-10-10       Impact factor: 7.853

7.  5-HT(4) receptors on cholinergic nerves involved in contractility of canine and human large intestine longitudinal muscle.

Authors:  N H Prins; L M Akkermans; R A Lefebvre; J A Schuurkes
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

8.  5-HT decreases contractile and electrical activities in lymphatic vessels of the guinea-pig mesentery: role of 5-HT 7-receptors.

Authors:  Alice K Chan; Pierre-Yves von der Weid
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

Review 9.  Prucalopride: a review of its use in the management of chronic constipation.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

10.  The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo.

Authors:  D T Beattie; J A M Smith; D Marquess; R G Vickery; S R Armstrong; T Pulido-Rios; J L McCullough; C Sandlund; C Richardson; N Mai; P P A Humphrey
Journal:  Br J Pharmacol       Date:  2004-10-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.